WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 8601 Infant (under 12 months) mortality rate: 472
GDP / capita (US$): 1'8591 Child (under 5 years) mortality rate: 712

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 15'603  15'246  14'898  14'565  14'256  12'500  10'485  7'289 
Births 539  537  534  528  520  410  389  344 
Surviving infants 515  513  508  502  493  381  366  321 
Pop. less than 5 years 2'505  2'460  2'406  2'345  2'279  1'838  1'787  1'454 
Pop. less than 15 years 6'491  6'340  6'189  6'046  5'916  5'338  4'833  3'567 
Female 15-49 years 4'001  3'904  3'810  3'720  3'634  3'055  2'370  1'531 

Number of reported cases

(Click for retrospective incidence data for Zimbabwe)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  1'483  13'728  23'650 
Mumps
ChartChart
 
Pertussis
ChartChart
  491  6'290 
Polio*
ChartChart
  32 
Rubella
ChartChart
  1'130  130  20  447 
Rubella (CRS)
ChartChart
  63 
Tetanus (neonatal)
ChartChart
  16  16  134 
Tetanus (total)**
ChartChart
  28  139 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Zimbabwe)
Vaccine year result method % card seen                                                
BCG 2014  98  CES   89  98  99  95  98  98  82  74 
DTP1 2014  98  CES   89  98  98  98  99  99  90 
DTP3 2014  96  CES   89  96  91  95  95  93  77  78 
DTP4          83 
IPV1         
HepB_BD          90 
HepB3 2014  96  CES   89  96  91  95  93  77 
Hib3 2014  96  CES   89  96  91  95  93 
JapEnc         
MCV1          94  92  93  97  92  70  76 
MCV2         
PCV1          97  98  98  99 
PCV3 2014  96  CES   89  95  91  95  95 
Pol3 2014  96  CES   89  96  92  95  95  93  70  78 
Rota1          97  94 
RotaC          96  82 
Rubella1         
TT2plus 2013  32  MICS   81  58  75  85  80  60  43 
PAB         
VAD1          49  19  95  91 
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Zimbabwe)
BCG
ChartChart
  90  99  95  98  98  84  91 
DTP1
ChartChart
  94  98  98  99  99  84  96 
DTP3
ChartChart
  87  91  95  95  93  78  88 
HepB3
ChartChart
  87  91  95  97  94  79 
HepB_BD
ChartChart
 
Hib3
ChartChart
  87  91  95  97  94 
IPV1
ChartChart
 
MCV1
ChartChart
  86  92  93  97  92  75  87 
MCV2
ChartChart
 
PAB
ChartChart
  75  75  66  66  66  76  57 
PCV3
ChartChart
  87  91  95  21 
Pol3
ChartChart
  88  92  95  95  93  78  89 
RCV1
ChartChart
 
RotaC
ChartChart
  87  48 

Number of districts in the country 63  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
   
/
|
|
\
Greater or equal to 90% 30
From 80 to 89% 38
From 50 to 79% 32
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 18 months; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
MR 9, 18 months; Yes
Measles 9 months; Yes
OPV 6, 10, 14 weeks; 18 months; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
TT 1st contact; +4 weeks; +6 months; Yes CBAW
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2015-2019  2012-2016  2012-2016  2012-2016  2011-2013  2008-2013  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 63  63  63  62  63    62 

System performance

Total Nº districts in country number 63  63  63  62  63  60  62 
Nº districts with DTP3 coverage >=80% number 57  56  55  44  35  27  19 
% of districts with DTP3 coverage >=80% From 0 to 100% 90  89  87  71  56  45  31 
Nº districts with measles (MCV1) coverage >=95% number 23  35  34  31  21 
% of districts with MCV1 coverage >=95% From 0 to 100% 37  56  54  50  33  15 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 30  36  14  68   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.